Although cyclometalated Ir<sup>III</sup> complexes have emerged as promising photosensitizers for photodynamic therapy, some key drawbacks still hamper clinical translation, such as operability in the phototherapeutic window and reactive oxygen species (ROS) production efficiency and selectivity. In...
No comments yet
Be the first to share your thoughts!